PTHS
Financials
- Market Capitalization 88.07 M
- Employee 92
- Founded 2002
- CEO N/A
- Website www.pelthos.com
- Headquarter Nevada, United States
- FIGI BBG01C9YP5V5
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3768 |  CNTN Canton Strategic Holdings, Inc. - Common Stock | 2.30 USD | +1.32% | -6.50% | -29.88% | -51.58% | 160.55 M USD | ||
| 3952 |  PLYX Polaryx Therapeutics, Inc. - Common Stock | 2.26 USD | +2.73% | -12.40% | -2.59% | -94.98% | 107.00 M USD | ||
| 4129 |  SCLX Scilex Holding Company - Common Stock | 8.76 USD | -7.20% | -9.22% | +37.30% | +7.75% | 74.38 M USD | ||
| 4130 |  OSTX OS Therapies Incorporated Common Stock | 1.67 USD | +2.45% | +12.08% | -3.47% | +45.22% | 74.38 M USD |
Frequently asked questions about Pelthos Therapeutics Inc. Common Stock
What is the Pelthos Therapeutics Inc. Common Stock stock price today?
The current price of Pelthos Therapeutics Inc. Common Stock (PTHS) is 25.34. Over the past 24 hours, the stock has changed by -4.16%. Follow the PTHS chart for real-time price dynamics.
What is the stock ticker of Pelthos Therapeutics Inc. Common Stock?
Pelthos Therapeutics Inc. Common Stock trades under the ticker PTHS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Pelthos Therapeutics Inc. Common Stock stock going up?
PTHS has changed by +0.40% over the last week, -7.38% over the last month, and +24.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Pelthos Therapeutics Inc. Common Stock net income for the last quarter?
Pelthos Therapeutics Inc. Common Stock reported net income of -10.24 M for the last quarter. The previous quarter showed -21.66 M, which means net income changed by +52.74%.
How many employees does Pelthos Therapeutics Inc. Common Stock have?
As of the latest available data, Pelthos Therapeutics Inc. Common Stock has 92 employees. Workforce size can provide additional context about the company's scale and operations.
What is Pelthos Therapeutics Inc. Common Stock EBITDA?
Pelthos Therapeutics Inc. Common Stock EBITDA is -11.39 M, and its EBITDA margin is -104.47%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Pelthos Therapeutics Inc. Common Stock stock?
You can buy Pelthos Therapeutics Inc. Common Stock (PTHS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Pelthos Therapeutics Inc. Common Stock stock?
Investing in Pelthos Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PTHS chart and related analysis on metatrader.com as part of your research.